News & Articles

NYU school of medicine becomes the most recent cancer center to join PanFAM-1 prospective study

The trial demonstrates that first-line pembrolizumab treatment improved overall and progression-free survival rates in patients with metastatic nonsquamous non-small cell lung cancer

The primary endpoint for first-line nivolumab-ipilimumab combo trial indicates improved progression-free survival in patients with advanced non-small cell lung cancer

Expansion of circulating tumor-specific T cells after nivolumab treatment suggests systemic antitumor immunity in patients with resectable lung cancer

The FT819 CAR T cell line has the potential to be mass-produced, stored, and made readily available for cancer immunotherapy

Crizotinib yielded a high objective response rate for adult patients with ALK-positive Inflammatory myofibroblastic tumor, and a 100 percent disease control rate

Research reveals that acquired HER2 mutations confer resistance to hormone therapy in ER-positive metastatic breast cancer

CHANGE-MS study confirms safety of GNbAC1 and reveals positive results related to neuroprotection in Multiple Sclerosis

New experimental drugs reduce hot flushes in menopausal women by almost three-quarters in just three days

How research at the AMR Centre, UK, is accelerating the fight against antimicrobial resistance

Fluctuations in female sex hormones could play a role in the development of allergies and asthma, a major review of evidence suggests

PRIMA, miniaturized wireless photovoltaic sub-retinal implant, elicited visual perception in the first human subject with Atrophic Dry-AMD

Mr. Alajoki, senior scientist at the technical research center of finland VTT, discusses next generation printed sensors.

Comprehensive immune profiling & monitoring

Salk researchers identify the molecular target of J147, which is nearing clinical trials to treat Alzheimer’s disease

ADVANCE trial expected to initiate patient recruitment shortly in several other EU countries, followed by the US

Mathematical models are used to analyse lymph node morphology and predict risk of cancer spread